State-wise disparities and temporal trends in acute myeloid leukemia (AML) in the United States of America (USA).

IF 2.2 4区 医学 Q3 HEMATOLOGY
Rupayan Kundu, Kriti Soni, Rishabh Kundu, Sudipto Mukherjee
{"title":"State-wise disparities and temporal trends in acute myeloid leukemia (AML) in the United States of America (USA).","authors":"Rupayan Kundu, Kriti Soni, Rishabh Kundu, Sudipto Mukherjee","doi":"10.1080/10428194.2025.2515598","DOIUrl":null,"url":null,"abstract":"<p><p>Acute myeloid leukemia (AML) is the most common acute leukemia in adults. We utilized Global Burden of Diseases 2021 data to assess age-standardized incidence rates (ASIR), age-standardized death rates (ASDR) per 100,000 population, and annual percentage changes (APC) of ASIR and ASDR of AML across USA states. Statistical modeling, including 2 two-sample t-test, was done. In 2021, the USA reported 21,533 AML cases (ASIR: 3.85) and 16,648 deaths (ASDR: 2.91). Both ASIR and ASDR increased from 1990 to 2021, particularly among individuals aged 70 years and older. In 2021, Kentucky and West Virginia had the highest ASIR and ASDR, respectively. From 1900 to 2021, metabolic risks related to AML death increased, while behavioral and occupational risks related to death declined. The growing AML burden in the USA, especially among older adults, underscores the need for age-sensitive care, preventive strategies targeting modifiable risks like obesity and smoking, and equitable healthcare access across states.</p>","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":" ","pages":"1-6"},"PeriodicalIF":2.2000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2025.2515598","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute myeloid leukemia (AML) is the most common acute leukemia in adults. We utilized Global Burden of Diseases 2021 data to assess age-standardized incidence rates (ASIR), age-standardized death rates (ASDR) per 100,000 population, and annual percentage changes (APC) of ASIR and ASDR of AML across USA states. Statistical modeling, including 2 two-sample t-test, was done. In 2021, the USA reported 21,533 AML cases (ASIR: 3.85) and 16,648 deaths (ASDR: 2.91). Both ASIR and ASDR increased from 1990 to 2021, particularly among individuals aged 70 years and older. In 2021, Kentucky and West Virginia had the highest ASIR and ASDR, respectively. From 1900 to 2021, metabolic risks related to AML death increased, while behavioral and occupational risks related to death declined. The growing AML burden in the USA, especially among older adults, underscores the need for age-sensitive care, preventive strategies targeting modifiable risks like obesity and smoking, and equitable healthcare access across states.

美国急性髓性白血病(AML)的州际差异和时间趋势。
急性髓性白血病(AML)是成人最常见的急性白血病。我们利用全球疾病负担2021数据来评估美国各州AML的年龄标准化发病率(ASIR)、每10万人的年龄标准化死亡率(ASDR)以及ASIR和ASDR的年百分比变化(APC)。进行统计建模,包括2个双样本t检验。2021年,美国报告了21,533例AML病例(ASIR: 3.85)和16,648例死亡(ASDR: 2.91)。从1990年到2021年,ASIR和ASDR都有所增加,尤其是在70岁及以上的人群中。2021年,肯塔基州和西弗吉尼亚州的ASIR和ASDR分别最高。从1900年到2021年,与AML死亡相关的代谢风险增加,而与死亡相关的行为和职业风险下降。在美国,尤其是在老年人中,AML负担不断增加,这强调了对年龄敏感的护理,针对肥胖和吸烟等可改变风险的预防策略以及各州公平医疗保健的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Leukemia & Lymphoma
Leukemia & Lymphoma 医学-血液学
CiteScore
4.10
自引率
3.80%
发文量
384
审稿时长
1.8 months
期刊介绍: Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信